A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

NCT07188558 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Large B-cell Lymphoma
Lymphoma, B-Cell
Relapsed Non-Hodgkin Lymphoma
Refractory Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma Refractory/ Relapsed
Diffuse Large B Cell Lymphoma (DLBCL)
Diffuse Large B Cell Lymphoma Refractory
Diffuse Large B Cell Lymphoma Relapsed

Interventions

BIOLOGICAL: rondecabtagene autoleucel
BIOLOGICAL: axicabtagene ciloleucel
BIOLOGICAL: lisocabtagene maraleucel

Sponsor

Lyell Immunopharma, Inc.